#VisualAbstract: Gene therapy improves bilirubin levels in Crigler-Najjar syndrome

Click here to read the study in NEJM

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

RELATED REPORTS

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

Neonatal Hyperbilirubinemia and navigating the 2022 AAP guideline updates

#VisualAbstract: Gene therapy improves bilirubin levels in Crigler-Najjar syndrome

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

Neonatal Hyperbilirubinemia and navigating the 2022 AAP guideline updates

Oral lipid nanocrystal amphotericin B may be effective for cryptococcal meningitis

Daily matcha consumption may improve resistance training-induced adaptation in muscle

RelatedReports

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

Neonatal Hyperbilirubinemia and navigating the 2022 AAP guideline updates

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

Daily matcha consumption may improve resistance training-induced adaptation in muscle

Vitamin D3 supplementation may improve relapse-free survival for certain digestive tract cancers

Risk of persistent opioid use postpartum is overall equivocal for patients prescribed oxycodone versus codeine

2MM+ All Access

Look up any US clinician

Recent Reports

Get the app

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits